These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8066546)
1. On the procedures for isolation of S9 fractions from induced rodents in in vitro genotoxicity assays. Paolini M; Biagi GL; Bauer C; Cantelli-Forti G Teratog Carcinog Mutagen; 1994; 14(2):101-3. PubMed ID: 8066546 [No Abstract] [Full Text] [Related]
2. Evaluation of phenobarbital/beta-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays. Callander RD; Mackay JM; Clay P; Elcombe CR; Elliott BM Mutagenesis; 1995 Nov; 10(6):517-22. PubMed ID: 8596471 [TBL] [Abstract][Full Text] [Related]
3. Isolation of S9 fractions from mouse and rat with increased enzyme activities after repeated administration of cytochrome P-450 and P-448 inducers. Paolini M; Sapigni E; Hrelia P; Grilli S; Cantelli-Forti G Mutagenesis; 1988 May; 3(3):239-43. PubMed ID: 3045486 [TBL] [Abstract][Full Text] [Related]
4. Isolation of a novel metabolizing system enriched in phase-II enzymes for short-term genotoxicity bioassays. Paolini M; Pozzetti L; Silingardi P; Della Croce C; Bronzetti G; Cantelli-Forti G Mutat Res; 1998 Mar; 413(3):205-17. PubMed ID: 9651530 [TBL] [Abstract][Full Text] [Related]
5. The influence of exogenous metabolism on the specificity of in vitro mammalian genotoxicity tests. Tate MJ; Walmsley RM Mutagenesis; 2017 Oct; 32(5):491-499. PubMed ID: 28992092 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing. Burke DA; Wedd DJ; Herriott D; Bayliss MK; Spalding DJ; Wilcox P Mutagenesis; 1994 Jan; 9(1):23-9. PubMed ID: 8208127 [TBL] [Abstract][Full Text] [Related]
7. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish. Guobaitis RJ; Ellingham TJ; Maddock MB Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989 [TBL] [Abstract][Full Text] [Related]
8. Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. Elliott BM; Combes RD; Elcombe CR; Gatehouse DG; Gibson GG; Mackay JM; Wolf RC Mutagenesis; 1992 May; 7(3):175-7. PubMed ID: 1602970 [TBL] [Abstract][Full Text] [Related]
9. Advantage of the use of human liver S9 in the Ames test. Hakura A; Suzuki S; Satoh T Mutat Res; 1999 Jan; 438(1):29-36. PubMed ID: 9858674 [TBL] [Abstract][Full Text] [Related]
10. N-benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays. Mori Y; Koide A; Fuwa K; Kobayashi Y Mutagenesis; 2001 Nov; 16(6):479-86. PubMed ID: 11682638 [TBL] [Abstract][Full Text] [Related]
11. In vitro mammalian cell genotoxicity assays: their use and interpretation. McGregor D Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003 [No Abstract] [Full Text] [Related]
12. Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles. García Franco S; Domínguez G; Pico JC Mutagenesis; 1999 May; 14(3):323-6. PubMed ID: 10375000 [TBL] [Abstract][Full Text] [Related]
13. Wide spectrum detection of precarcinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome P450 isoenzymes. Paolini M; Sapigni E; Hrelia P; Scotti M; Morotti M; Cantelli-Forti G Carcinogenesis; 1991 May; 12(5):759-66. PubMed ID: 1903089 [TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolite profiles generated in Aroclor-induced rat liver and human liver subcellular fractions: considerations for in vitro genotoxicity hazard assessment. Obach RS; Dobo KL Environ Mol Mutagen; 2008 Oct; 49(8):631-41. PubMed ID: 18626997 [TBL] [Abstract][Full Text] [Related]
15. In vitro activation assays with hepatic S9 preparation from wild and laboratory reared woodchucks in the Salmonella mutagenicity test. Rashid KA; Babish JG; Mumma RO Toxicology; 1988 Jan; 48(1):53-9. PubMed ID: 3122370 [TBL] [Abstract][Full Text] [Related]
16. S9 induction by the combined treatment with cyclohexanol and albendazole. Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644 [TBL] [Abstract][Full Text] [Related]
17. The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9. Oberly TJ; Scheuring JC; Richardson KA; Richardson FC; Garriott ML Mutat Res; 1993 Apr; 299(2):77-84. PubMed ID: 7680426 [TBL] [Abstract][Full Text] [Related]
18. The effect of colupulone (a HOPS beta-acid) on hepatic cytochrome P-450 enzymatic activity in the rat. Shipp EB; Mehigh CS; Helferich WG Food Chem Toxicol; 1994 Nov; 32(11):1007-14. PubMed ID: 7959454 [TBL] [Abstract][Full Text] [Related]
19. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034 [TBL] [Abstract][Full Text] [Related]
20. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment. Traynor CA; Shane BS; Hajos AK; Winston GW Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]